Return to search results.
Complete title: A Proof-of-concept Clinical Trial of Intratumoral Injection of GLA-SE, a Toll-like Receptor-4 Agonist, in Patients with Merkel Cell Carcinoma
|Research Study Number||8072|
|Principal Investigator||Shailender Bhatia, MD|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Other eligibility criteria may apply.
Skin Cancer; Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.